BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Silveira C, Guedes R, Maia D, Curral R, Coelho R. Neuropsychiatric Symptoms of Multiple Sclerosis: State of the Art. Psychiatry Investig 2019;16:877-88. [PMID: 31805761 DOI: 10.30773/pi.2019.0106] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Filser M, Buchner A, Fink GR, Gold SM, Penner IK. The manifestation of affective symptoms in multiple sclerosis and discussion of the currently available diagnostic assessment tools. J Neurol 2022. [PMID: 36129540 DOI: 10.1007/s00415-022-11359-6] [Reference Citation Analysis]
2 Brandão PMF, Lino TB, Oliveira RT, Parra AV, Andrade PHM, Christofoletti G. Age, motor dysfunction and neuropsychiatric symptoms impact quality of life in multiple sclerosis. Rev Bras Enferm 2022;75:e20210207. [PMID: 35674578 DOI: 10.1590/0034-7167-2021-0207] [Reference Citation Analysis]
3 Hosseini Z, Homayuni A, Etemadifar M. Barriers to quality of life in patients with multiple sclerosis: a qualitative study. BMC Neurol 2022;22:174. [PMID: 35562707 DOI: 10.1186/s12883-022-02700-7] [Reference Citation Analysis]
4 Ghahremani A, Mosa Farkhani S, Baniasadi M, Hojjat SK, Namdar Ahmadabad H, Salarbashi D, Elyasi S, Davoodian N. Personality traits of patients with multiple sclerosis and their correlation with anxiety and depression levels: A cross-sectional case-control study. Brain Behav 2022;:e2596. [PMID: 35452562 DOI: 10.1002/brb3.2596] [Reference Citation Analysis]
5 Fernandes DJ, Spring S, Corre C, Tu A, Qiu LR, Hammill C, Vousden DA, Spencer Noakes TL, Nieman BJ, Bowdish DME, Foster JA, Palmert MR, Lerch JP. Mouse models of immune dysfunction: their neuroanatomical differences reflect their anxiety-behavioural phenotype. Mol Psychiatry. [DOI: 10.1038/s41380-022-01535-5] [Reference Citation Analysis]
6 Zaratin P, Banwell B, Coetzee T, Comi G, Feinstein A, Hyde R, Salvetti M, Smith K. Researching COVID-19 in progressive MS requires a globally coordinated, multi-disciplinary and multi-stakeholder approach-perspectives from the International Progressive MS Alliance. Mult Scler J Exp Transl Clin 2022;8:20552173221099181. [PMID: 35530174 DOI: 10.1177/20552173221099181] [Reference Citation Analysis]
7 Celani MG, Nonino F, Mahan K, Orso M, Ridley B, Baldin E, Bignamini AA, D'Amico R, Cantisani TA, Colombo C, Khan F, Köpke S, Laurson-Doube J, Schvarz C, Young CA, Peryer G, Rosati P, Filippini G. Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting project. Mult Scler Relat Disord 2022;60:103688. [PMID: 35245817 DOI: 10.1016/j.msard.2022.103688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cheniaux E. The bipolarity of Alberto Santos-Dumont: flights and falls of the “Father of Aviation”. J bras psiquiatr . [DOI: 10.1590/0047-2085000000364] [Reference Citation Analysis]
9 Kim S, Lee EJ, Kim KW, Seo D, Moon S, Kim KK, Lim YM. Quality of life of patients with multiple sclerosis and neuromyelitis optica spectrum disorders: Cross-sectional and longitudinal analysis. Mult Scler Relat Disord 2022;58:103500. [PMID: 35032884 DOI: 10.1016/j.msard.2022.103500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Azoulai M, Lévy-heidmann T, Morisseau V, Wilczynski O, Le HH, Jamieson C, Charvet LE, Krupp LB, Lair L. A novel disease specific scale to characterize the symptoms and impacts of fatigue in US adults with relapsing multiple sclerosis: A real-world study. Multiple Sclerosis and Related Disorders 2022. [DOI: 10.1016/j.msard.2022.103637] [Reference Citation Analysis]
11 Özbudak P, Erçelebi H, Gücüyener K. Psychosis: a rare onset symptom of pediatric multiple sclerosis. Neurocase 2021;:1-3. [PMID: 34927555 DOI: 10.1080/13554794.2021.2016859] [Reference Citation Analysis]
12 Datta S, Suryadevara U, Cheong J. Mood Disorders. Continuum (Minneap Minn) 2021;27:1712-37. [PMID: 34881733 DOI: 10.1212/CON.0000000000001051] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Cristiano E, Abad P, Becker J, Carrá A, Correale J, Flores J, Fruns M, Garcea O, Garcia Bónitto J, Gracia F, Hamuy F, Navas C, Patrucco L, Rivera V, Velazquez M, Rojas JI. Multiple sclerosis care units in Latin America: Consensus recommendations about its objectives and functioning implementation. J Neurol Sci 2021;429:118072. [PMID: 34509134 DOI: 10.1016/j.jns.2021.118072] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Sabe M, Sentissi O. Psychotic symptoms prior or concomitant to diagnosis of multiple sclerosis: a systematic review of case reports and case series. Int J Psychiatry Clin Pract 2021;:1-7. [PMID: 34487465 DOI: 10.1080/13651501.2021.1973506] [Reference Citation Analysis]
15 Tencer T, Will O, Kumar J, Cambron-Mellott MJ, Mackie DS, Beusterien K. Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experiment. Curr Med Res Opin 2021;37:1589-98. [PMID: 34129418 DOI: 10.1080/03007995.2021.1940911] [Reference Citation Analysis]
16 Amini P, Almasi-Hashiani A, Sahraian MA, Najafi M, Eskandarieh S. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series. BMC Neurol 2021;21:235. [PMID: 34167483 DOI: 10.1186/s12883-021-02281-x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Menculini G, Chipi E, Paolini Paoletti F, Gaetani L, Nigro P, Simoni S, Mancini A, Tambasco N, Di Filippo M, Tortorella A, Parnetti L. Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis. Int J Mol Sci 2021;22:4440. [PMID: 33922780 DOI: 10.3390/ijms22094440] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
18 Davis BE, Lakin L, Binns CC, Currie KM, Rensel MR. Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review. Neurol Ther 2021;10:99-119. [PMID: 33877584 DOI: 10.1007/s40120-021-00240-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
19 Lakin L, Davis BE, Binns CC, Currie KM, Rensel MR. Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms-A Narrative Review. Neurol Ther 2021;10:75-98. [PMID: 33877583 DOI: 10.1007/s40120-021-00239-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
20 Han A. Mindfulness- and Acceptance-Based Interventions for Symptom Reduction in Individuals With Multiple Sclerosis: A Systematic Review and Meta-Analysis. Arch Phys Med Rehabil 2021:S0003-9993(21)00260-4. [PMID: 33812883 DOI: 10.1016/j.apmr.2021.03.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ostolaza A, Corroza J, Ayuso T. Multiple sclerosis and aging: comorbidity and treatment challenges. Mult Scler Relat Disord 2021;50:102815. [PMID: 33581613 DOI: 10.1016/j.msard.2021.102815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 van der Meer D, Pinzón-Espinosa J, Lin BD, Tijdink JK, Vinkers CH, Guloksuz S, Luykx JJ. Associations between psychiatric disorders, COVID-19 testing probability and COVID-19 testing results: findings from a population-based study. BJPsych Open 2020;6:e87. [PMID: 32696734 DOI: 10.1192/bjo.2020.75] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
23 Sivolap YP, Azimova YE. [Anxiety in neurological practice]. Zh Nevrol Psikhiatr Im S S Korsakova 2020;120:165-70. [PMID: 32621484 DOI: 10.17116/jnevro2020120051165] [Reference Citation Analysis]
24 Văcăraș V, Văcăraș V, Nistor C, Văcăraș D, Opre AN, Blaga P, Mureșanu DF. The Influence of Depression and Anxiety on Neurological Disability in Multiple Sclerosis Patients. Behavioural Neurology 2020;2020:1-8. [DOI: 10.1155/2020/6738645] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]